Mirae Asset Global Investments’s CorMedix CRMD Stock Holding History

Mirae Asset Global Investments’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.5K	Sell	3,509 -601	-15%	-$4.75K	﹤0.01%	1455
2026 Q1	$27.9K	Buy	4,110 +281	+7%	+$2.08K	﹤0.01%	1386
2025 Q4	$44.5K	Buy	3,829 +943	+33%	+$10.4K	﹤0.01%	1419
2025 Q3	$33.6K	Buy	2,886 +266	+10%	+$3.22K	﹤0.01%	1412
2025 Q2	$32.3K	Buy	2,620 +610	+30%	+$6.73K	﹤0.01%	1321
2025 Q1	$13.5K	Sell	2,010 -12	-0.6%	-$124	﹤0.01%	1436
2024 Q4	$16.6K	Buy	+2,022	New	+$20.2K	﹤0.01%	1447
2024 Q1	–	Sell	-23,751	Closed	-$89.3K	–	2475
2023 Q4	$89.3K	Hold	23,751	–	–	﹤0.01%	2484
2023 Q3	$87.9K	Hold	23,751	–	–	﹤0.01%	2490
2023 Q2	$94.2K	Buy	+23,751	New	+$118K	﹤0.01%	2529

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Mirae Asset Global Investments's CRMD Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its CorMedix (CRMD) stake by 15% in Q2 2026, selling an estimated $4.75K and leaving 3,509 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1455.

Mirae Asset Global Investments first reported a position in CRMD in Q2 2023 and has held it in 10 quarters since. The position peaked at $94.2K in Q2 2023. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Mirae Asset Global Investments held 3,509 shares of CorMedix worth $27.5K as of Q2 2026.
Mirae Asset Global Investments sold 601 CorMedix shares in Q2 2026, an estimated $4.75K.
CorMedix made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1455 holding.
Mirae Asset Global Investments first reported a position in CorMedix in Q2 2023 and has held it in 10 quarters since.
Mirae Asset Global Investments's CorMedix position peaked at $94.2K in Q2 2023.
193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.